Moderna Science Day Highlights Expanding Potential of mRNA Platform
Moderna, Inc. (NASDAQ:MRNA) today announced research and early development updates at its Science Day event. "As we execute our strategic plan to become a diversified, multi-modality biotechnology company, we are preparing to manage three commercial franchises, Infectious Disease Vaccines, Intismeran, and Rare Disease Therapeutics, while advancing a broad mRNA pipeline and continuing to invest in research and development," said Stéphane Bancel,...
Read more









